Skip to Content
Merck
CN
  • Acute massive pulmonary embolism associated with olanzapine therapy and no significant personal history in a young male--case report and literature review.

Acute massive pulmonary embolism associated with olanzapine therapy and no significant personal history in a young male--case report and literature review.

Pneumologia (Bucharest, Romania) (2011-08-10)
Marius Toringhibel, Tatiana Adam, Oana-Cristina Arghir, Eleonora Gima
ABSTRACT

We report the case of a 28 years old, non-smoker male with a massive pulmonary embolism and left pleural effusion associated and probably induced by olanzapine 10 mg once daily in the previous 4 months, completely recovered after 18 days of stopping the antipsychotic and trombolytic treatment. Thrombotic events have been reported with the use of antipsychotic compounds, although the incidence, predisposing factors, and biological mechanisms associated with these events in psychiatric patients are subject to debate.

MATERIALS
Product Number
Brand
Product Description

Supelco
Olanzapine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
Olanzapine, United States Pharmacopeia (USP) Reference Standard
Olanzapine, European Pharmacopoeia (EP) Reference Standard
Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard